The aim of this study is to investigate the long-term follow-up of the previously conducted FOAM study.
It describes the long-term quality of life (QoL) after ultrasound guided foam sclerotherapy (UGFS) and surgical stripping, outcomes with regard to clinical, and ultrasound recurrence, progression of venous disease, predictive value of the presence of central / deep venous obstruction for recurrence of varicose veins and the long term cost analysis. Recurrence of varicose veins was defined as the presence of one or more venous symptoms such as pain, cramps, restless legs and a tired/heavy feeling in the treated leg, in combination with the presence of reflux longer than 0·5 s. The initial definition of recurrent reflux, which is defined as reflux for more than 2 cm in length in the treated vein segment (proximal great saphenous vein (GSV) ) as measured by colour flow duplex ultrasound (DUS). DUS findings of the treated proximal GSV were categorized as: 1, absence of reflux; 2, reflux; 3, occlusion; 4, partial occlusion with reflux; 5, absence of vein, is being used. Patients in categories 2 and 4 are considered to have reflux.
Study Type
OBSERVATIONAL
Enrollment
460
Department of Dermatology, Atrium Medical Centre.
Heerlen, Limburg, Netherlands
RECRUITINGMaastricht UMC+
Maastricht, Limburg, Netherlands
RECRUITINGDepartments of Dermatology and Surgery, Laurentius Hospital
Roermond, Limburg, Netherlands
RECRUITINGlong-term QoL follow-up of patients after UGFS and surgical stripping
Time frame: 6-10 years follow-up
Clinical recurrence
Time frame: 6-10 years follow-up
Technical recurrence
Vein closure rates
Time frame: 6-10 years follow-up
Number of retreatments
Time frame: 6-10 years follow-up
Venous Clinical Severity Score change
Time frame: 6-10 years follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.